SCHEMBL7920797

SCHEMBL7920797

C=C(CCCCC)c1ccccc1S

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.39
CES2 O00748 2/20 0.39
CES1 P23141 2/20 0.39
TP53 P04637 1/20 0.39
CYP3A4 P08684 1/20 0.39
MAPK1 P28482 1/20 0.39
MAPT P10636 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
LMNA P02545 2/20 0.38
ALDH1A1 P00352 1/20 0.38
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
RECQL P46063 1/20 0.37
KMT2A Q03164 1/20 0.37
TDP1 Q9NUW8 2/20 0.36
HTT P42858 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
EPHX2 P34913 1/20 0.35
CA12 O43570 1/20 0.35
CA9 Q16790 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23891572 0.95 MEN1 (0.41) TSHRCES2CES1TP53CYP3A4
SCHEMBL6046923 0.87 TSHR (0.44) TSHRCES2CES1TP53CYP3A4
SCHEMBL10791012 0.80 TSHR (0.40) TSHRCES2CES1TP53CYP3A4
SCHEMBL7923699 0.80 NAAA (0.49) TSHRCES2CES1TP53CYP3A4
SCHEMBL29175153 0.80 MAOA (0.50) TSHRCES2CES1TP53CYP3A4
SCHEMBL19940285 0.79 MAPT (0.45) TSHRTP53MAPTHDAC8LMNA
SCHEMBL7918288 0.79 ALDH1A1 (0.50) TSHRCES2CES1TP53CYP3A4
SCHEMBL27268186 0.79 HPGD (0.49) TSHRCES2CES1TP53CYP3A4
SCHEMBL15676413 0.77 MAPT (0.51) TSHRCES2CES1TP53CYP3A4
SCHEMBL17975837 0.77 MAPT (0.51) TSHRCES2CES1TP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235923-B1 RETINOIDS AND CELL DIFFERENTIATION ALLERGAN SALES, INC. 2001-05-22 US disclosed
US-6225494-B1 TREATING SKIN DISORDERS, REDUCED SIDE EFFECTS ALLERGAN SALES, INC. 2001-05-01 US disclosed
US-6037488-A COMPOUNDS SUCH AS 4-((4'-ISOPROPOXY-3'-(1-M-TOLYL)VINYL)PHENYLETHYNYL)BENZOIC ACID ALLERGAN SALES, INC. (US) 2000-03-14 US disclosed
EP-0975573-A1 TRISUBSTITUTED PHENYL DERIVATIVES HAVING RETINOID AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY Allergan Sales, Inc. (US) 2000-02-02 EP disclosed
WO-1998047854-A1 TRISUBSTITUTED PHENYL DERIVATIVES HAVING RETINOID AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY ALLERGAN SALES, INC. (US) 1998-10-29 WO disclosed